Vir Biotechnology Inc (VIR)

Jun 14, 2026

VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership - Stocktwits

Jun 14, 2026

Jun 14, 2026

Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million - AOL.com

Jun 14, 2026

Jun 12, 2026

VIR Should I Buy - Intellectia AI

Jun 12, 2026

Jun 12, 2026

Why Did Vir Biotechnology Stock Surge 60% After-Hours Today? - Stocktwits

Jun 12, 2026

Jun 11, 2026

VIR Maintained by Morgan Stanley -- Price Target Raised to $27 - GuruFocus

Jun 11, 2026

Jun 11, 2026

Morgan Stanley Raises Vir Biotechnology (NASDAQ:VIR) Price Target to $27.00 - MarketBeat

Jun 11, 2026

Jun 11, 2026

Vir Biotechnology, Inc. Stock 12‑Month Price Target Raised to $21.56, Implies 161% Upside - TradingView

Jun 11, 2026

Jun 11, 2026

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors - BioSpace

Jun 11, 2026

Jun 10, 2026

Vir Biotechnology (VIR) director awarded RSUs and stock options in new grants - Stock Titan

Jun 10, 2026

Jun 10, 2026

Vir Biotechnology (VIR) director Coughlin reports zero share ownership - Stock Titan

Jun 10, 2026

Jun 10, 2026

Vir Biotechnology Adds Timothy Coughlin to Board, Audit Chair - TipRanks

Jun 10, 2026

Jun 10, 2026

Vir Biotechnology appoints Timothy Coughlin to board - Investing.com UK

Jun 10, 2026

Jun 10, 2026

Vir Biotechnology appoints Timothy Coughlin to board By Investing.com - Investing.com South Africa

Jun 10, 2026

Jun 10, 2026

Vir Biotechnology (VIR) appoints Timothy Coughlin as director and Audit Committee chair - Stock Titan

Jun 10, 2026

Jun 10, 2026

WINTON GROUP Ltd Buys 131,555 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat

Jun 10, 2026

Jun 09, 2026

Vir Biotechnology: Analyzing the Bullish Thesis on VIR-5500 and mCRPC OpportunityAnalyst Coverage Count - newsline.com

Jun 09, 2026

Jun 08, 2026

VIR News | VIR BIOTECHNOLOGY INC (NASDAQ:VIR) - ChartMill

Jun 08, 2026

Jun 07, 2026

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now? - Insider Monkey

Jun 07, 2026

Jun 06, 2026

Earnings call transcript: Vir Biotech reports larger-than-expected Q1 2026 loss - Investing.com

Jun 06, 2026

Jun 05, 2026

Vir Biotech Q1 2026 presentation: $2.2B partnerships fuel oncology pivot - Investing.com

Jun 05, 2026

Jun 03, 2026

VIR Maintained by Leerink Partners -- Price Target Raised to $21 - GuruFocus

Jun 03, 2026

Jun 03, 2026

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00 - MarketBeat

Jun 03, 2026

Jun 03, 2026

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology I - GuruFocus

Jun 03, 2026

Jun 02, 2026

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotech - GuruFocus

Jun 02, 2026

Jun 02, 2026

Vir Biotechnology director Janet Napolitano sells $30,239 in stock - Investing.com UK

Jun 02, 2026

Jun 02, 2026

Vir Biotechnology director Janet Napolitano sells $30,239 in stock By Investing.com - Investing.com India

Jun 02, 2026

Jun 02, 2026

Vir Biotechnology (VIR) director Napolitano sells 3,200 shares under 10b5-1 plan - Stock Titan

Jun 02, 2026

Jun 02, 2026

Vir Biotechnology (VIR) SVP sells 379 shares in pre-planned trade - Stock Titan

Jun 02, 2026

Jun 01, 2026

VIR (NASDAQ: VIR) Form 144 lists 379 ESPP shares; insider sold 7,711 - Stock Titan

Jun 01, 2026

Jun 01, 2026

[144] Vir Biotechnology, Inc. SEC Filing - Stock Titan

Jun 01, 2026

Jun 01, 2026

Barclays Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Jun 01, 2026

May 30, 2026

Vir Biotechnology, Inc. (VIR) Presents at EASL Congress 2026Slideshow (NASDAQ:VIR) 2026-05-30 - Seeking Alpha

May 30, 2026

May 28, 2026

Vir Biotechnology (VIR) director receives RSU and stock option grants - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology (VIR) director granted 8,000 RSUs and 16,000 options - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology (VIR) director granted RSUs and 16,000-share stock option - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology (VIR) director receives 8,000 RSUs and 16,000 stock options - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology (VIR) director awarded 8,000 RSUs and 16,000-share stock option - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology (VIR) director granted RSUs and 16,000-share option - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology, Inc. 8-K Filing Details for May 25, 2026: Company Information, NASDAQ Listing, and Executive Certification - Minichart

May 28, 2026

May 28, 2026

Vir Biotechnology, Inc. Announces Changes in Board and Audit Committee, Effective May 26, 2026 - marketscreener.com

May 28, 2026

May 28, 2026

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), GeoVax Labs (GOVX) and Vir Biotechnology (VIR) - The Globe and Mail

May 28, 2026

May 28, 2026

Vir Biotechnology (Nasdaq: VIR) reports director exit and 2026 vote outcomes - Stock Titan

May 28, 2026

May 28, 2026

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

May 28, 2026

May 27, 2026

Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally - AOL.com

May 27, 2026

May 27, 2026

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat

May 27, 2026